Home › Trial NCT01710319
Mechanisms of Immunosurveillance for Lung Cancer
- Trial IDNCT01710319
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorWashington University School of Medicine
- Enrollment119
- Start date2012-09
- ConditionsLung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.